NovoCure (NVCR) Total Debt Growth (5y) (2020 - 2026)
NovoCure (NVCR) Total Debt Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | NovoCure | 1.93 Bn | 1.50 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.97% |
| Dec 31, 2025 | -14.62% |
| Jun 30, 2025 | -8.17% |
| Mar 31, 2025 | -8.20% |
| Dec 31, 2024 | -8.22% |
| Sep 30, 2024 | -8.25% |
| Jun 30, 2024 | -8.28% |
| Mar 31, 2024 | 30.71% |
| Sep 30, 2023 | 30.65% |
| Jun 30, 2023 | 30.61% |
| Mar 31, 2023 | 30.58% |
| Dec 31, 2022 | 42.18% |
| Sep 30, 2022 | 42.22% |
| Jun 30, 2022 | 42.26% |
| Mar 31, 2022 | 42.30% |
| Dec 31, 2021 | 42.34% |
| Sep 30, 2021 | 42.37% |
| Jun 30, 2021 | 88.92% |
| Mar 31, 2021 | 89.02% |
| Dec 31, 2020 | 404.92% |